Literature DB >> 31559514

Process optimization for the rapid production of Enterovirus 71.

Xiao-Xin Wu1, Ke-Da Chen1, Da-Zhi Chen1, Lan-Lan Xiao1, Kai-Zhou Huang1, Yan-Jun Zhang2, Lan-Juan Li3.   

Abstract

Enterovirus 71 (EV71) infection can cause hand-foot-and-mouth disease (HFMD). Inactivated EV71 vaccine was effective to prevent EV71 derived HFMD. A highly efficient and economical process for producing EV71 is needed. In our study, the epidemic strain of EV71 (EV71-2013ZJHFMD) was obtained and purified. The Vero cells were cultured for production of EV71. The mini-bioreactor vessel (Amprotein Inc., China) packed with a 0.6 g polymer fiber carrier was used to determine the best seeding cell density, multiplicity of infection (MOI) and temperature. Then the optimized procedure was further applied in a 10 L disposable perfusion bioreactor ACPB (AmProtein Current Perfusion Bioreactor). The Vero cell culture and viral titer were monitored. The seeding density of 1.5 × 107 cells per 0.6 g disk was considered to be the most appropriate for the culture. The best MOI was 0.1 and the temperature was 32 °C. The total cell number increased from 1.5 × 109 to 3.0 × 1010. The maximum viral titers reached 1.0 × 108/mL 3 days post-infection in our optimized special culture procedure (serum-free during the harvest period, supplemented with 0.25% Lactalbumin Hydrolysate). The total volume of the harvested supernatant was 25 L and the total virus yield was 1.93 × 1012. The procedure using Vero cells grown on polymer fiber paper carriers was effective for the large-scale production of EV71.

Entities:  

Keywords:  Disposable perfusion bioreactor; Enterovirus 71; Hand–foot-and-mouth disease; Mini-bioreactor; Polymer fiber paper carriers; Vero cells

Year:  2019        PMID: 31559514      PMCID: PMC6874637          DOI: 10.1007/s10616-019-00340-3

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  29 in total

1.  Application of a serum-free medium for the growth of Vero cells and the production of reovirus.

Authors:  M Butler; A Burgener; M Patrick; M Berry; D Moffatt; N Huzel; N Barnabé; K Coombs
Journal:  Biotechnol Prog       Date:  2000 Sep-Oct

2.  Process optimization for the rapid production of adenoviral vectors for clinical trials in a disposable bioreactor system.

Authors:  Ke-Da Chen; Xiao-Xin Wu; Dong-Shan Yu; Hui-Lin Ou; Yan-Hua Li; Yu-Qing Zhou; Lan-Juan Li
Journal:  Appl Microbiol Biotechnol       Date:  2018-06-02       Impact factor: 4.813

3.  High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.

Authors:  Chia-Chyi Liu; Wei-Cheng Lian; Michael Butler; Suh-Chin Wu
Journal:  Vaccine       Date:  2006-08-02       Impact factor: 3.641

Review 4.  Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis.

Authors:  Bingyi Yang; Peng Wu; Joseph T Wu; Eric H Y Lau; Gabriel M Leung; Hongjie Yu; Benjamin J Cowling
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

5.  Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate.

Authors:  Ya-Ching Lin; Cheng-Nan Wu; Shin-Ru Shih; Mei-Shang Ho
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

6.  Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.

Authors:  Suh-Chin Wu; Chia-Chyi Liu; Wei-Cheng Lian
Journal:  Vaccine       Date:  2004-09-28       Impact factor: 3.641

7.  Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.

Authors:  Alan Yung-Chih Hu; Yu-Fen Tseng; Tsai-Chuan Weng; Chien-Chun Liao; Johnson Wu; Ai-Hsiang Chou; Hsin-Ju Chao; Anna Gu; Janice Chen; Su-Chen Lin; Chia-Hsin Hsiao; Suh-Chin Wu; Pele Chong
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

8.  Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Cheng-Peng Chang; Meng-Shin Guo; Shih-Yang Hsieh; Wen-Hsueh Yang; Hsin-Ju Chao; Chien-Long Wu; Ju-Lan Huang; Min-Shi Lee; Alan Yung-Chi Hu; Sue-Chen Lin; Yu-Yun Huang; Mei-Hua Hu; Yen-Hung Chow; Jen-Ron Chiang; Jui-Yuan Chang; Pele Chong
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

9.  Spatiotemporal Dynamics of Hand-Foot-Mouth Disease and Its Relationship with Meteorological Factors in Jiangsu Province, China.

Authors:  Wendong Liu; Hong Ji; Jun Shan; Jin Bao; Yan Sun; Juan Li; Changjun Bao; Fenyang Tang; Kun Yang; Robert Bergquist; Zhihang Peng; Yefei Zhu
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

10.  Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.

Authors:  Saki Takahashi; Qiaohong Liao; Thomas P Van Boeckel; Weijia Xing; Junling Sun; Victor Y Hsiao; C Jessica E Metcalf; Zhaorui Chang; Fengfeng Liu; Jing Zhang; Joseph T Wu; Benjamin J Cowling; Gabriel M Leung; Jeremy J Farrar; H Rogier van Doorn; Bryan T Grenfell; Hongjie Yu
Journal:  PLoS Med       Date:  2016-02-16       Impact factor: 11.069

View more
  1 in total

Review 1.  Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects.

Authors:  Zhongbiao Fang; Jingting Lyu; Jianhua Li; Chaonan Li; Yuxuan Zhang; Yikai Guo; Ying Wang; Yanjun Zhang; Keda Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.